94
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Frequent expression of the Epstein–Barr virus encoded BZLF1 protein in angioimmunoblastic T-cell lymphoma

&
Pages 677-679 | Received 17 Dec 2012, Accepted 21 May 2013, Published online: 10 Jul 2013

References

  • Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
  • Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003;121:681–691.
  • Attygalle AD, Kyriakou C, Dupuis J, et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007;31:1077–1088.
  • Grogg KL, Attygalle AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 2006;19:1101–1107.
  • Piccaluga PP, Agostinelli C, Califano A, et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 2007;67:10703–10710.
  • Anagnostopoulos I, Hummel M, Stein H. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leuk Lymphoma 1995;19:1–12.
  • Weiss LM, Jaffe ES, Liu XF, et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992;79:1789–1795.
  • Anagnostopoulos I, Hummel M, Finn T, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992;80:1804–1812.
  • Amon W, Farrell PJ. Reactivation of Epstein-Barr virus from latency. Rev Med Virol 2005;15:149–156.
  • Rooney CM, Rowe DT, Ragot T, et al. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 1989;63:3109–3116.
  • Dunleavy K, Wilson WH. Angioimmunoblastic T-cell lymphoma: immune modulation as a therapeutic strategy. Leuk Lymphoma 2007;48:449–451.
  • Pizzolo G, Chilosi M, Fiore-Donati L, et al. Imbalance of peripheral blood and lymph node T cell subpopulations in angioimmunoblastic lymphadenopathy. Report of three cases. Haematologica 1983;68: 591–599.
  • Ganesan TS, Dhaliwal HS, Dorreen MS, et al. Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study. Br J Cancer 1987;55:437–442.
  • Zhou Y, Attygalle AD, Shih-Sung C, et al. Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV8 viral load. Br J Haematol 2007;138:44–53.
  • Battegay M, Berger C, Rochlitz C, et al. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Antivir Ther 2004;9:453–459.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.